2,3,6-trimethyl-1,4-naphthoquinone has been researched along with naphthoquinones in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Castagnoli, KP; Castagnoli, N; Petzer, JP; Steyn, SJ; Van der Schyf, CJ | 1 |
| Castagnoli, N; Gairola, CG; Miller, RT; Venkatakrishnan, P | 1 |
| Budzianowski, J | 1 |
1 review(s) available for 2,3,6-trimethyl-1,4-naphthoquinone and naphthoquinones
| Article | Year |
|---|---|
[Tobacco--once a medicinal plant. Does it contain substances with medicinal properties?].
Topics: Animals; Brain; Comorbidity; Humans; Monoamine Oxidase; Naphthoquinones; Neuroprotective Agents; Nicotiana; Nicotine; Nitric Oxide Synthase Type I; Parkinson Disease; Phytotherapy; Plants, Medicinal; Receptors, Nicotinic; Smoking | 2013 |
2 other study(ies) available for 2,3,6-trimethyl-1,4-naphthoquinone and naphthoquinones
| Article | Year |
|---|---|
Neuroprotection in the MPTP Parkinsonian C57BL/6 mouse model by a compound isolated from tobacco.
Topics: Animals; Brain; Disease Models, Animal; Dopamine; Mice; Mice, Inbred C57BL; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Naphthoquinones; Neostriatum; Neuroprotective Agents; Nicotiana; Parkinsonian Disorders; Plant Extracts; Plants, Toxic | 2001 |
Naphthoquinones and bioactive compounds from tobacco as modulators of neuronal nitric oxide synthase activity.
Topics: Chromatography, High Pressure Liquid; Citrulline; Enzyme Inhibitors; NADP; Naphthoquinones; Nicotiana; Nitric Oxide Synthase Type I; Oxidation-Reduction; Plant Extracts; Vitamin K 3 | 2009 |